Drugs / IGT001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06936787 | Apr → Dec 2025 overdue | retinitis pigmentosa | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IGT001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06936787 ↗ |
| Route | Intravitreal | “intravitreal injection” NCT06936787 ↗ |